Recombinant Human CD47, His (HEK293-expressed) 是在 HEK293 中產(chǎn)生的帶有 His 標(biāo)簽的多肽鏈。CD47 是癌癥免疫療法的重要靶標(biāo)。
Synonyms
rHuCD47, His; CD47; MER6; IAP; OA3
Species
HumanSource
HEK 293 Accession
Q08722 Gene ID
961 Molecular Weight
35-40 kDa AA Sequence
QLLFNKTKSV EFTFCNDTVV IPCFVTNMEA QNTTEVYVKW KFKGRDIYTF DGALNKSTVP TDFSSAKIEV SQLLKGDASL KMDKSDAVSH TGNYTCEVTE LTREGETIIE LKYRVVSWFS PHHHHHH Biological Activity
2 μg/mL (100 μL/well) of immoblized recombinant human CD47-His can bind human SIRPa-Fc with a linear range of 20-65 ng/mL. Appearance
Lyophilized powder. Formulation
Lyophilized after extensive dialysis against PBS. Endotoxin Level
<0.2 EU/μg, determined by LAL method. Reconstitution
Reconstitute the lyophilized recombinant Human CD47, His (HEK293-expressed) (rHuCD47, His) to 100 μg/mL using ddH2O or diluted with PBS. Storage & Stability
Lyophilized recombinant Human CD47, His (HEK293-expressed) (rHuCD47, His) is stored at -20°C. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer. It is recommended to freeze aliquots at -20°C or -80°C for extended storage. Shipping
Room temperature in continental US; may vary elsewhere. Background
Targeting CD47 is in the spotlight of cancer immunotherapy. Blocking CD47 triggers the recognition and elimination of cancer cells by the innate immunity. The CD47/SIRP-α axis has been established as an important regulator of innate anti-cancer immunity, with many if not all malignancies overexpressing the receptor CD47 that binds to phagocyte-expressed SIRP-α[1]. |
